+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07237685

Studying How Heart Artery Disease Progresses in Adults with Type 2 Diabetes Using Heart Scans

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-11-20

1000

Participants Needed

2

Research Sites

521 weeks

Total Duration

AI-Summary

What This Trial Is About

People with type 2 diabetes face a higher risk of heart disease, especially when blood vessels supplying the heart narrow or become blocked by fatty deposits called plaque. This condition can cause serious problems like chest pain or heart attacks. The trial aims to understand how heart disease progresses over time in people with type 2 diabetes by studying changes in their hearts blood vessels using special scans. Participants who have previously had a coronary CT angiography CCTA scan will be followed. This scan provides detailed pictures of the hearts blood vessels to detect plaque buildup. Researchers will compare the initial scan with follow-up scans taken between 2 and 5 years later to observe changes in total coronary plaque volume and other related heart health indicators. During the study, participants heart scans and health information will be reviewed to track plaque progression and other risk factors. The primary measurement is the change in total plaque volume between the baseline and follow-up scans. Secondary measures include changes in plaque types, calcium scores, and cardiovascular events. The study will continue to monitor cardiovascular events for up to 10 years after enrollment.

CONDITIONS

Brief Title

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

Research Team

W

Willem R van de Vijver, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here